Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future

Cell Host & Microbe(2020)10.1016/j.chom.2020.07.007Source: DataRank Database

Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future is a research paper published in Cell Host & Microbe (2020). On theSindex it has a DataRank of 0. It has been cited 230 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access230 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 14.51)OA: bronzeTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Bernd Schnabl ORCID,Sonja Lang ORCID

Live enrichment

PubMed:32791115 PMC:PMC7467841 OpenAlex:https://openalex.org/W3048394674

NIAAA NIH HHS

Grant: P50 AA011999

NIAAA NIH HHS

Grant: R01 AA020703

NIAAA NIH HHS

Grant: R01 AA024726

BLRD VA

Grant: I01 BX004594

NIDDK NIH HHS

Grant: P30 DK120515

NIAAA NIH HHS

Grant: U01 AA026939

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Deutsche Forschungsgemeinschaft

Biomedical Laboratory Research and Development, VA Office of Research and Development

FWCI

14.51

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1931312820304030/pdf

publisherhttp://www.cell.com/article/S1931312820304030/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312820304030?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312820304030?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2020.07.007

Fields of Study

Liver Disease Diagnosis and TreatmentGut microbiota and healthAlcohol Consumption and Health Effects0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsDysbiosisFatty Liver, AlcoholicGastrointestinal MicrobiomeHost Microbial InteractionsHumansIntestinesLiverMiceNon-alcoholic Fatty Liver DiseaseProbiotics

MeSH Terms

Gastrointestinal MicrobiomeHost Microbial InteractionsAnimalsFatty Liver, AlcoholicHumansIntestinesLiverProbioticsMiceDysbiosisNon-alcoholic Fatty Liver Disease

Keywords

Fatty liverBiologyDiseaseMicrobiomeGut floraLiver diseasePathogenesisBioinformaticsImmunologyPathologyMedicineBiochemistryNon-alcoholic fatty liver diseaseMetagenomicsNon-alcoholic SteatohepatitisNASHAlcoholic HepatitisAlcohol Use DisorderNafldAldAlcohol-associated Liver DiseaseHost Microbial InteractionsProbioticsGastrointestinal MicrobiomeIntestinesMiceLiverAnimalsDysbiosisHumansFatty Liver, Alcoholic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals

Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future

FAIR Checklist

Authors (2)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)